China clears CanSinoBIO COVID-19 vaccine for clinical trials - National | Globalnews.ca
CanSino Biologics Inc's mRNA COVID-19 vaccine approved for clinical trials in China, joining other domestic candidates. China, with 88% of its population vaccinated, has not approved foreign mRNA vaccines. CanSinoBIO's candidate showed high-level antibodies against variants, including Omicron, in pre-clinical studies.
Reference News
China clears CanSinoBIO COVID-19 vaccine for clinical trials - National | Globalnews.ca
CanSino Biologics Inc's mRNA COVID-19 vaccine approved for clinical trials in China, joining other domestic candidates. China, with 88% of its population vaccinated, has not approved foreign mRNA vaccines. CanSinoBIO's candidate showed high-level antibodies against variants, including Omicron, in pre-clinical studies.